Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa.
about
Pharmacogenetics of antipsychotic-induced movement disorders as a resource for better understanding Parkinson's disease modifier genesPyridoxine improves drug-induced parkinsonism and psychosis in a schizophrenic patientPersistent Drug-Induced Parkinsonism in Patients with Normal Dopamine Transporter ImagingParkinson's disease and neuropsychological assessment.Clinical Implications of Cardiac-MIBG SPECT in the Differentiation of Parkinsonian Syndromes.Tardive and idiopathic oromandibular dystonia: a clinical comparison.An adverse drug interaction of haloperidol with levodopaA magneto-inductive sensor based wireless tongue-computer interfaceDrug-induced movement disorders in children and adolescents.Cardiac 123I-MIBG scintigraphy in patients with drug induced parkinsonism.Odour identification test and its relation to cardiac 123I-metaiodobenzylguanidine in patients with drug induced parkinsonismDrug Insight: from disturbed motility to disordered movement--a review of the clinical benefits and medicolegal risks of metoclopramide.The spectrum of orolingual tremor--a proposed classification system.Neuroleptic-induced Parkinsonism: Clinicopathological study.Imaging dopamine transporters in Parkinson's disease.Drug-induced parkinsonism in the elderly: incidence, management and prevention.Co-occurrence of parkinsonism and dementia in clinical practice: relevant differential diagnoses.Treating psychosis in movement disorder patients: a review.Not all drug-induced parkinsonism are the same: the effect of drug class on motor phenotype.Graves' disease presenting as hemiparkinsonism.Relationship between adverse effects of antipsychotic treatment and dopamine D(2) receptor polymorphisms in patients with schizophrenia.Neuroradiological covariates of drug-induced parkinsonism and tardive dyskinesia in schizophrenia.Microstructural white matter alterations in patients with drug induced parkinsonism.Clinical features of drug-induced parkinsonism based on [18F] FP-CIT positron emission tomography.Risk factors for neuroleptic-induced movement disorders.Asymmetric Drug-Induced Parkinsonism and Psychopathology: A Prospective Naturalistic Study in Long-Stay Psychiatric Patients.
P2860
Q28088705-E2349A20-F976-4255-A664-EAB912164355Q28332518-BFBC22DB-DC05-47C9-9F63-F7F52752932BQ28550219-57DE23BE-D3A3-450F-93ED-24F53F0AC96DQ33737505-4404D438-FDFF-4C60-BA89-A75F2303F196Q33790729-E4A43F1E-D14D-441A-83CE-B9749A33795CQ35455187-306A3C69-70FC-4AA8-BD18-341334B1E4E6Q35564995-F3B68B80-A436-4E23-AFAB-6273D8B31D64Q35752404-28E05336-BACC-4194-ABCF-430F6D5B8115Q36040766-A7E06215-01B4-4977-B106-DA1ADC0B1BF8Q36143071-949C124E-CB0A-442C-94DC-CDBCA9974B73Q36226750-8F2A582A-7847-474C-BEFA-3DCDFDE248EAQ36411104-061B9840-5A07-48B9-AF74-686F05F65230Q36987107-DCF592DE-8C09-433F-B5F4-21222B1D97B1Q37340484-A4D0DE99-0B58-4BA4-B4C0-4883CE48E246Q37800096-5D700901-E7A0-470B-9ADA-F689BC1FCD3AQ37976411-AC445C2B-FF4E-41E9-8130-B78C0159404FQ37978747-F8D42FC6-13F8-4606-9F46-6F85747368CFQ38213306-F33A23B1-B58E-48E6-98F1-B6C856602790Q39181633-A20712EE-2739-46BC-878E-24B28403AE2FQ43583606-26A60D2E-0631-46AE-95FE-778A9FBD571AQ44112135-197C6F9C-C0E9-42EE-819C-D8B9DBD3A9A3Q45098438-C22037E9-0370-419D-8E70-6C8C2E51150EQ47681149-EDDD2AF9-45ED-44F1-BA2D-ED30949CE966Q48534930-5B689B5E-AA4B-4F37-8687-DBEEC0991153Q48620261-3FF61833-2F8D-459E-A0DB-2A982F3D7183Q50014594-820DF3E1-4246-40A8-B8A7-A1580B596C09
P2860
Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa.
description
1988 nî lūn-bûn
@nan
1988 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Neuroleptic-induced Parkinson' ...... ts of treatment with levodopa.
@ast
Neuroleptic-induced Parkinson' ...... ts of treatment with levodopa.
@en
type
label
Neuroleptic-induced Parkinson' ...... ts of treatment with levodopa.
@ast
Neuroleptic-induced Parkinson' ...... ts of treatment with levodopa.
@en
prefLabel
Neuroleptic-induced Parkinson' ...... ts of treatment with levodopa.
@ast
Neuroleptic-induced Parkinson' ...... ts of treatment with levodopa.
@en
P2860
P356
P1476
Neuroleptic-induced Parkinson' ...... ts of treatment with levodopa.
@en
P2093
P2860
P304
P356
10.1136/JNNP.51.6.850
P407
P577
1988-06-01T00:00:00Z